Skip to main content
PMC home page
Heart logoLink to Heart
. 2000 Oct;84(4):438–441. doi: 10.1136/heart.84.4.438

Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline

D SKUDICKY 1, K SLIWA 1, A BERGEMANN 1, G CANDY 1, P SARELI 1
PMCID: PMC1729442  PMID: 10995419

Full Text

The Full Text of this article is available as a PDF (192.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belloc F., Jaloustre C., Dumain P., Lacombe F., Lenoble M., Boisseau M. R. Effect of pentoxifylline on apoptosis of cultured cells. J Cardiovasc Pharmacol. 1995;25 (Suppl 2):S71–S74. doi: 10.1097/00005344-199500252-00015. [DOI] [PubMed] [Google Scholar]
  2. Cowie M. R., Struthers A. D., Wood D. A., Coats A. J., Thompson S. G., Poole-Wilson P. A., Sutton G. C. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet. 1997 Nov 8;350(9088):1349–1353. doi: 10.1016/S0140-6736(97)06031-5. [DOI] [PubMed] [Google Scholar]
  3. Davidson N. C., Naas A. A., Hanson J. K., Kennedy N. S., Coutie W. J., Struthers A. D. Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. Am J Cardiol. 1996 Apr 15;77(10):828–831. doi: 10.1016/S0002-9149(97)89176-X. [DOI] [PubMed] [Google Scholar]
  4. Hancox J. C., Patel K. C., Jones J. V. Antiarrhythmics--from cell to clinic: past, present, and future. Heart. 2000 Jul;84(1):14–24. doi: 10.1136/heart.84.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hegewisch S., Weh H. J., Hossfeld D. K. TNF-induced cardiomyopathy. Lancet. 1990 Feb 3;335(8684):294–295. doi: 10.1016/0140-6736(90)90115-l. [DOI] [PubMed] [Google Scholar]
  6. Hirota H., Chen J., Betz U. A., Rajewsky K., Gu Y., Ross J., Jr, Müller W., Chien K. R. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell. 1999 Apr 16;97(2):189–198. doi: 10.1016/s0092-8674(00)80729-1. [DOI] [PubMed] [Google Scholar]
  7. Mallat Z., Philip I., Lebret M., Chatel D., Maclouf J., Tedgui A. Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation. 1998 Apr 28;97(16):1536–1539. doi: 10.1161/01.cir.97.16.1536. [DOI] [PubMed] [Google Scholar]
  8. McDonagh T. A., Robb S. D., Murdoch D. R., Morton J. J., Ford I., Morrison C. E., Tunstall-Pedoe H., McMurray J. J., Dargie H. J. Biochemical detection of left-ventricular systolic dysfunction. Lancet. 1998 Jan 3;351(9095):9–13. doi: 10.1016/s0140-6736(97)03034-1. [DOI] [PubMed] [Google Scholar]
  9. Moore K., Roberts L. J., 2nd Measurement of lipid peroxidation. Free Radic Res. 1998 Jun;28(6):659–671. doi: 10.3109/10715769809065821. [DOI] [PubMed] [Google Scholar]
  10. Morrow J. D., Hill K. E., Burk R. F., Nammour T. M., Badr K. F., Roberts L. J., 2nd A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A. 1990 Dec;87(23):9383–9387. doi: 10.1073/pnas.87.23.9383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Narula J., Haider N., Virmani R., DiSalvo T. G., Kolodgie F. D., Hajjar R. J., Schmidt U., Semigran M. J., Dec G. W., Khaw B. A. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 1996 Oct 17;335(16):1182–1189. doi: 10.1056/NEJM199610173351603. [DOI] [PubMed] [Google Scholar]
  12. Netzer R. O., Zollinger E., Seiler C., Cerny A. Infective endocarditis: clinical spectrum, presentation and outcome. An analysis of 212 cases 1980-1995. Heart. 2000 Jul;84(1):25–30. doi: 10.1136/heart.84.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nourooz-Zadeh J., Gopaul N. K., Barrow S., Mallet A. I., Anggård E. E. Analysis of F2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure. J Chromatogr B Biomed Appl. 1995 May 19;667(2):199–208. doi: 10.1016/0378-4347(95)00035-h. [DOI] [PubMed] [Google Scholar]
  14. O'Connor C. M., Gurbel P. A., Serebruany V. L. Usefulness of soluble and surface-bound P-selectin in detecting heightened platelet activity in patients with congestive heart failure. Am J Cardiol. 1999 May 1;83(9):1345–1349. doi: 10.1016/s0002-9149(99)00098-3. [DOI] [PubMed] [Google Scholar]
  15. Sliwa K., Skudicky D., Candy G., Wisenbaugh T., Sareli P. Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy. Lancet. 1998 Apr 11;351(9109):1091–1093. doi: 10.1016/S0140-6736(97)09338-0. [DOI] [PubMed] [Google Scholar]
  16. Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 1993 Dec 17;75(6):1169–1178. doi: 10.1016/0092-8674(93)90326-l. [DOI] [PubMed] [Google Scholar]
  17. Walsh J. T., Batin P. D., Hawkins M., McEntegart D., Cowley A. J. Ventricular dilatation in the absence of ACE inhibitors: influence of haemodynamic and neurohormonal variables following myocardial infarction. Heart. 1999 Jan;81(1):33–39. doi: 10.1136/hrt.81.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES